![Careers in Discovery](https://pbcdn1.podbean.com/imglogo/image-logo/18676005/1478977-1674819143110-a9f40d319527c.jpg)
1.5K
Downloads
138
Episodes
Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influential figures, the work they are doing, how they got to where they are and what advice they’d give their younger selves. Brought to you by Singular: Building Brilliant Biotechs. Connect with us at: LinkedIn: https://www.linkedin.com/company/singular-biotech/ www.singular-biotech.com
Episodes
![Hazel Jones, Enhanc3d Genomics](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/Copy_of_CiD_-_Peter_Pack_grqf87_300x300.png)
4 days ago
Hazel Jones, Enhanc3d Genomics
4 days ago
4 days ago
This week I’m joined by Hazel Jones, CEO of Enhanc3d Genomics. Hazel shares her journey from her early days in Biotech to leading a company at the cutting edge of 3D genomics.
We explored Hazel's career path, her transition into a CEO role and her insights on leadership, the significance of networking, and balancing professional and personal life.
![Peter Pack](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/CiD_-_Peter_Pack_1__s3iz3v_300x300.png)
Wednesday Jul 17, 2024
Peter Pack
Wednesday Jul 17, 2024
Wednesday Jul 17, 2024
This week on Careers in Discovery, we are joined by Peter Pack, an influential figure in the biotechnology industry with a career spanning over two decades.
Peter's journey has taken him from Germany to the dynamic biotech landscape of the UK, where he now operates as a strategic partner and advisor to private equity firms and startups.
In our conversation, Peter shares his diverse experiences, including his time as a CEO for nearly 20 years and his current role mentoring young biotech teams. He offers insights into the differences between the biotech industries in Germany and the UK, the importance of building strong networks, and his passion for supporting innovative startups.
Peter also reflects on his early inspirations in science, the development of groundbreaking technologies at Morphosys, and the valuable lessons he has learned about commercialization and strategic decision-making. He emphasizes the importance of collaboration, learning from mistakes, and the critical role of supportive investors.
Join us as we explore Peter's fascinating career, his views on the future of biotech, and the key factors that contribute to successful leadership in this ever-evolving field.
Don't miss this episode full of insights from a biotech veteran who continues to shape the industry.
![Jose Munoz-Olaya, Valink Therapeutics](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/CiD_-_Jose_Munoz-Olaya_s4e297_300x300.png)
Wednesday Jul 10, 2024
Jose Munoz-Olaya, Valink Therapeutics
Wednesday Jul 10, 2024
Wednesday Jul 10, 2024
"Science and technology have always fascinated me, and I've always been one to challenge the status quo."
This week on Careers in Discovery, we welcome Jose Munoz-Olaya, Chief Scientific Officer of Valink Therapeutics.
Jose shares his journey from an eager intern to a leader in biotechnology, emphasizing the importance of mentorship and the power of teamwork. He discusses his role at Valink, where he's spearheading the development of next-generation Antibody-Drug Conjugates (ADCs) for oncology using their innovative high-throughput screening platform.
Join us as Jose discusses:
- His early inspiration from a high school science teacher and his diverse family background
- The critical milestones of his career, including his influential roles at Cambridge Antibody Technology, F-star, and Adaptate
- Lessons learned about the importance of building strong teams and fostering a culture of continuous learning
- His advice for aspiring scientists: trust your mentors, be patient, and remain open to learning
Tune in for all this, and much more....
![Mike Stubbington, CS Genetics](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/CiD_-_Mike_Stubbington_gwkfp2_300x300.png)
Wednesday Jul 03, 2024
Mike Stubbington, CS Genetics
Wednesday Jul 03, 2024
Wednesday Jul 03, 2024
Mike Stubbington and CS Genetics are on a mission to democratise single cell genomics. We caught up with Mike recently and discussed what being kind really looks like as a scientist, why you should move on when the time is right, and a whole lot more.
![Ben Cross, PhoreMost](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/CiD_-_Ben_Cross_1__rb73vm_300x300.png)
Wednesday Jun 26, 2024
Ben Cross, PhoreMost
Wednesday Jun 26, 2024
Wednesday Jun 26, 2024
We first interviewed Ben Cross five years ago, when he was the Head of Functional Genomics at Horizon Discovery, and we're delighted to welcome him back to the podcast as CTO of PhoreMost, an innovative target discovery company focused on drugging the undruggable.
Ben caught us up on what he's learned over the last five years, including why failing fast isn't a viable strategy in drug discovery, and introduced us to PhoreMost's brand new molecular glue platform, GlueSeeker.
![Shane Hegarty, Axonis Therapeutics](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/CiD_-_Shane_Hegarty_qwjr32_300x300.png)
Wednesday Jun 19, 2024
Shane Hegarty, Axonis Therapeutics
Wednesday Jun 19, 2024
Wednesday Jun 19, 2024
Shane Hegarty is the Chief Scientific Officer of Axonis Therapeutics, a Boston-based Biotech targeting KCC2 to revive neurons and treat people suffering from neurological disorders.
Shane shared with us the story of his transition from academic to Biotech entrepreneur, why communication, persistence, collaboration and focus are critical skills for success, his amazing track record of securing grant funding, and much more.
![Maude Tessier, Seismic Therapeutic](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/Copy_of_CiD_-_Vern_de_Biasi_h5m94g_300x300.png)
Wednesday Jun 12, 2024
Maude Tessier, Seismic Therapeutic
Wednesday Jun 12, 2024
Wednesday Jun 12, 2024
Maude Tessier is the Chief Business Officer at Seismic Therapeutic, the machine learning immunology company building a discovery platform centred on parallel drug development.
Maude joined us on Careers in Discovery to talk about the impact of machine learning on drug development, taking control of her career by literally knocking on doors, balancing humility and confidence, and much more.
![Vern de Biasi, BenevolentAI](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/CiD_-_Vern_de_Biasi_5j4gd7_300x300.png)
Wednesday Jun 05, 2024
Vern de Biasi, BenevolentAI
Wednesday Jun 05, 2024
Wednesday Jun 05, 2024
Vern de Biasi is VP of Business Development at BenevolentAI, one of the world's leaders in the application of cutting edge technology to drug discovery.
Vern's career has seen him travel the world, from the UK to Italy, China and the US, and he shared with us the key lessons he's learned along the way.
![Image](https://pbcdn1.podbean.com/fs1/user-site-dist/assets/customize-component4.png)
Your Title
This is the description area. You can write an introduction or add anything you want to tell your audience. This can help potential listeners better understand and become interested in your podcast. Think about what will motivate them to hit the play button. What is your podcast about? What makes it unique? This is your chance to introduce your podcast and grab their attention.